Coya Therapeutics' COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, today announced ...
Healio

Non-pharmacological therapy may benefit hand function in systemic sclerosis

Please provide your email address to receive an email when new articles are posted on . Patients with systemic sclerosis reported an improved ability to perform daily tasks when receiving ...
Healio

Occupational exposure to toxicants may predict lung function decline in systemic sclerosis

Please provide your email address to receive an email when new articles are posted on . Among patients with systemic sclerosis, occupational exposure to toxicants independently predicted decline in ...